TMED vs. UPGI, OCQLF, ISOL, TFSVF, TDCH, ACCMF, ABQQ, ACNV, LOQPF, and AELTF
Should you be buying Trimedyne stock or one of its competitors? The main competitors of Trimedyne include (UPGI) (UPGI), 01 Communique Laboratory (OCQLF), 1mage Software (ISOL), 24SevenOffice Group AB (publ) (TFSVF), 30DC (TDCH), AAC Clyde Space AB (publ) (ACCMF), AB International Group (ABQQ), Accelera Innovations (ACNV), accesso Technology Group (LOQPF), and Adacel Technologies (AELTF). These companies are all part of the "computer and technology" sector.
(UPGI) (OTCMKTS:UPGI) and Trimedyne (OTCMKTS:TMED) are both computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, community ranking, media sentiment, analyst recommendations, institutional ownership, dividends, valuation and profitability.
In the previous week, (UPGI)'s average media sentiment score of 0.00 equaled Trimedyne's average media sentiment score.
Trimedyne received 66 more outperform votes than (UPGI) when rated by MarketBeat users.
Trimedyne beats (UPGI) on 1 of the 1 factors compared between the two stocks.
Media Sentiment Over Time
This chart shows the average media sentiment of OTCMKTS and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Trimedyne Competitors List
Related Companies and Tools